We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Bayer HealthCare

Bayer's radiology division provides diagnostic imaging solutions, which includes medical devices, contrast media, int... read more Featured Products: More products

Download Mobile App




Gadolinium Contrast Agent Approved for Supra-Aortic MRI Angiography

By MedImaging International staff writers
Posted on 19 May 2016
Print article
A gadolinium-based contrast agents (GBCA) indicated for use with magnetic resonance angiography (MRA) has been approved for evaluating supra-aortic or renal artery disease.

Gadavist, a product of Bayer (Leverkusen, Germany) was previously indicated for use with magnetic resonance imaging (MRI) in adult and pediatric patients (including term neonates) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system (CNS). It is also indicated for use with MRI to assess the presence and extent of malignant breast disease.

In MRI, visualization of normal and pathological tissue depends on variations in the radiofrequency (RF) signal intensity that occurs with differences in proton density, differences of spin-lattice (longitudinal) relaxation times (T1), and differences in the spin-spin (transverse) relaxation time (T2). When placed in a magnetic field, Gadavist shortens the T1 and T2 relaxation times, depending on the concentration in the tissue, the field strength of the MRI system, and the relative ratio of the longitudinal and transverse relaxation times.

“Until now, no contrast agents were FDA-approved for use with MRA of the supra-aortic arteries,” said Elias Melhem, MD, chair of the department of diagnostic radiology & nuclear medicine at the University of Maryland, lead investigator for the Gadavist-Enhanced MRA of the Supra-Aortic Vessels (GEMSAV) study. “With FDA's action, radiologists now have an approved MRA contrast agent to help visualize supra-aortic arteries in patients with known or suspected supra-aortic arterial disease, including conditions such as prior stroke or transient ischemic attack.”

GBCAs increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired drug elimination of the drugs. NSF may result in fatal or debilitating fibrosis affecting the skin, muscle, and internal organs. The risk for NSF appears highest among patients with chronic, severe kidney disease or acute kidney injury (AKI).

Related Links:
Bayer

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Laptop Ultrasound Scanner
PL-3018
New
X-Ray Detector
FDR-D-EVO III
New
Ultrasound Table
Ergonomic Advantage (EA) Line

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.